newsfilter
← Latest News
Business Wire·

Dexcom Announced as First Participant Selected for FDA's TEMPO Digital Health Devices Pilot Program

Participation advances the company’s vision and regulatory pathway for earlier intervention, screening for prediabetes and Type 2 diabetes and empowerment Dexcom (NASDAQ:DXCM), the global leader in glucose